Coffee with the Expert

Professor Helen McShane FRCP PhD FMedSci is a leading British infectious disease physician and one of the world’s most influential figures in tuberculosis (TB) vaccine development. A Professor of Vaccinology at the University of Oxford and Director of the NIHR Oxford Biomedical Research Centre, she has dedicated more than two decades to advancing vaccines for some of the world’s most challenging infectious diseases.

Dr. Robert Cohen is a distinguished Professor of Pediatrics and Pediatric Infectious Diseases specialist at the Intercommunal Hospital of Créteil, France. A graduate of...

Authors: Enrique Chacon-Cruz, M.D., MSc Felicitas Colombo, MPA Dr. Mariagrazia Pizza is Professor of Microbiology and Co-Director of the Centre for Bacterial Resistance Biology (CBRB) at Imperial...

Authors: Enrique Chacon-Cruz, M.D., MSc Felicitas Colombo, MPA Dr. Rajeev Venkayya is a recognized global health leader with deep expertise in vaccines, pandemic preparedness, and biopharmaceutical innovation....

Authors: Enrique Chacon-Cruz, M.D., MSc Felicitas Colombo, MPA Prof. Alejandro Cravioto is a distinguished physician, researcher, and global health leader with decades of experience in medical education,...

Prof. Carol J. Baker is a renowned clinician, researcher, educator, and vaccinologist, internationally recognized for her pioneering contributions to pediatric infectious diseases and vaccine...

Professor Sue Ann Costa Clemens is a leading expert in Pediatric Infectious Diseases, Vaccinology, and Global Health. She currently serves as Co-founder and Professor...

Dr. Sheldon L. Kaplan is Professor of Pediatrics at Baylor College of Medicine in Houston, Texas, where he served as Head of the Section...

Professor Robert Steffen is internationally recognized as the "father of travel medicine." He not only coined the term but also initiated the world’s first...

Jerome H. Kim, M.D., serves as the Director General of the International Vaccine Institute (IVI) and is an international expert in vaccine development and evaluation. Before joining IVI, Dr. Kim held several prominent positions, including Principal Deputy of the U.S. Military HIV Research Program and Chief of the Laboratory of Molecular Virology and Pathogenesis at the Walter Reed Army Institute of Research. He was also the U.S. Army Program Manager for HIV vaccines and led the Army’s RV144 Phase III HIV vaccine trial, which demonstrated efficacy in preventing HIV-1.